These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1437 related articles for article (PubMed ID: 28579851)
1. Transformation of Follicular Lymphoma to a High-Grade B-Cell Lymphoma With MYC and BCL2 Translocations and Overlapping Features of Burkitt Lymphoma and Acute Lymphoblastic Leukemia: A Case Report and Literature Review. Bischin AM; Dorer R; Aboulafia DM Clin Med Insights Blood Disord; 2017; 10():1179545X17692544. PubMed ID: 28579851 [TBL] [Abstract][Full Text] [Related]
2. B-cell lymphomas with concurrent IGH-BCL2 and MYC rearrangements are aggressive neoplasms with clinical and pathologic features distinct from Burkitt lymphoma and diffuse large B-cell lymphoma. Snuderl M; Kolman OK; Chen YB; Hsu JJ; Ackerman AM; Dal Cin P; Ferry JA; Harris NL; Hasserjian RP; Zukerberg LR; Abramson JS; Hochberg EP; Lee H; Lee AI; Toomey CE; Sohani AR Am J Surg Pathol; 2010 Mar; 34(3):327-40. PubMed ID: 20118770 [TBL] [Abstract][Full Text] [Related]
3. Double-hit B-cell lymphomas with BCL6 and MYC translocations are aggressive, frequently extranodal lymphomas distinct from BCL2 double-hit B-cell lymphomas. Pillai RK; Sathanoori M; Van Oss SB; Swerdlow SH Am J Surg Pathol; 2013 Mar; 37(3):323-32. PubMed ID: 23348205 [TBL] [Abstract][Full Text] [Related]
5. De novo acute lymphoblastic leukemia-like disease of high grade B-cell lymphoma with Uchida A; Isobe Y; Uemura Y; Nishio Y; Sakai H; Kato M; Otsubo K; Hoshikawa M; Takagi M; Miura I BMC Clin Pathol; 2017; 17():21. PubMed ID: 29151814 [TBL] [Abstract][Full Text] [Related]
6. Clinical significance of 'double-hit' and 'double-expression' lymphomas. Ma Z; Niu J; Cao Y; Pang X; Cui W; Zhang W; Li X J Clin Pathol; 2020 Mar; 73(3):126-138. PubMed ID: 31615842 [TBL] [Abstract][Full Text] [Related]
8. Triple-hit B-cell Lymphoma With MYC, BCL2, and BCL6 Translocations/Rearrangements: Clinicopathologic Features of 11 Cases. Wang W; Hu S; Lu X; Young KH; Medeiros LJ Am J Surg Pathol; 2015 Aug; 39(8):1132-9. PubMed ID: 25828391 [TBL] [Abstract][Full Text] [Related]
9. Primary Diffuse Large B-Cell Lymphoma of the Breast with MYC and BCL2 Rearrangements with Terminal Deoxynucleotidyl Transferase Expression: A Case Report. Matar B; Chbat M; Bitar H; Rosado F Case Rep Oncol; 2024; 17(1):614-621. PubMed ID: 39015647 [TBL] [Abstract][Full Text] [Related]
10. A case of B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and Burkitt lymphoma in a Korean child. Ahn JY; Seo YH; Park PW; Kim KH; Park MJ; Jeong JH; Park SH; Song YH Ann Lab Med; 2012 Mar; 32(2):162-6. PubMed ID: 22389885 [TBL] [Abstract][Full Text] [Related]
11. [The role of translocations involving c-MYC/8q24, BCL2/18q21 and/or BCL6/3q27 genes in patients with follicular lymphoma. Retrospective analysis of single - centre data]. Misyurina AE; Kravchenko SK; Kovrigina AM; Magomedova AU; Plastinina LV; Obukhova TN; Misyurin AV; Misyurin VA; Grebenuk LA; Babaeva FE; Baryakh EA; Vorobiev AI Ter Arkh; 2019 Jul; 91(7):52-62. PubMed ID: 32598736 [TBL] [Abstract][Full Text] [Related]
12. Transformation of t(14;18)-negative follicular lymphoma to plasmablastic lymphoma: a case report with analysis of genetic evolution. Lim S; Koh J; Bae JM; Yun H; Lee C; Paik JH; Kim TM; Jeon YK Diagn Pathol; 2024 Jun; 19(1):86. PubMed ID: 38909266 [TBL] [Abstract][Full Text] [Related]
13. B-cell lymphomas with MYC/8q24 rearrangements and IGH@BCL2/t(14;18)(q32;q21): an aggressive disease with heterogeneous histology, germinal center B-cell immunophenotype and poor outcome. Li S; Lin P; Fayad LE; Lennon PA; Miranda RN; Yin CC; Lin E; Medeiros LJ Mod Pathol; 2012 Jan; 25(1):145-56. PubMed ID: 22002575 [TBL] [Abstract][Full Text] [Related]
14. Mutational landscape of high-grade B-cell lymphoma with Künstner A; Witte HM; Riedl J; Bernard V; Stölting S; Merz H; Olschewski V; Peter W; Ketzer J; Busch Y; Trojok P; Bubnoff NV; Busch H; Feller AC; Gebauer N Haematologica; 2022 Aug; 107(8):1850-1863. PubMed ID: 34788985 [TBL] [Abstract][Full Text] [Related]
15. Impact of oncogene rearrangement patterns on outcomes in patients with double-hit non-Hodgkin lymphoma. Landsburg DJ; Petrich AM; Abramson JS; Sohani AR; Press O; Cassaday R; Chavez JC; Song K; Zelenetz AD; Gandhi M; Shah N; Fenske TS; Jaso J; Medeiros LJ; Yang DT; Nabhan C Cancer; 2016 Feb; 122(4):559-64. PubMed ID: 26565895 [TBL] [Abstract][Full Text] [Related]
16. Case report: Mutation evolution in a patient with TdT positive high grade B cell lymphoma with MYC and BCL2 rearrangements following the treatment of concurrent follicular lymphoma and diffuse large B-cell lymphoma. Zhang F; Chen Y; Cui Q; Ge Y; Liu Y Discov Oncol; 2024 Apr; 15(1):129. PubMed ID: 38662249 [TBL] [Abstract][Full Text] [Related]
17. Double-hit and triple-hit lymphomas arising from follicular lymphoma following acquisition of MYC: report of two cases and literature review. Xu X; Zhang L; Wang Y; Zhang Q; Zhang L; Sun B; Zhang Y Int J Clin Exp Pathol; 2013; 6(4):788-94. PubMed ID: 23573328 [TBL] [Abstract][Full Text] [Related]
18. Double-Hit Gene Expression Signature Defines a Distinct Subgroup of Germinal Center B-Cell-Like Diffuse Large B-Cell Lymphoma. Ennishi D; Jiang A; Boyle M; Collinge B; Grande BM; Ben-Neriah S; Rushton C; Tang J; Thomas N; Slack GW; Farinha P; Takata K; Miyata-Takata T; Craig J; Mottok A; Meissner B; Saberi S; Bashashati A; Villa D; Savage KJ; Sehn LH; Kridel R; Mungall AJ; Marra MA; Shah SP; Steidl C; Connors JM; Gascoyne RD; Morin RD; Scott DW J Clin Oncol; 2019 Jan; 37(3):190-201. PubMed ID: 30523716 [TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of MYC, BCL2, and BCL6 rearrangements in patients with diffuse large B-cell lymphoma treated with cyclophosphamide, doxorubicin, vincristine, and prednisone plus rituximab. Akyurek N; Uner A; Benekli M; Barista I Cancer; 2012 Sep; 118(17):4173-83. PubMed ID: 22213394 [TBL] [Abstract][Full Text] [Related]
20. The "Burkitt-like" immunophenotype and genotype is rarely encountered in diffuse large B cell lymphoma and high-grade B cell lymphoma, NOS. Hüttl KS; Staiger AM; Richter J; Ott MM; Kalmbach S; Klapper W; Biesdorf AS; Trümper L; Rosenwald A; Ziepert M; Horn H; Ott G Virchows Arch; 2021 Sep; 479(3):575-583. PubMed ID: 33655392 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]